Printer Friendly
The Free Library
4,548,460 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Annual Walk of Hope to Benefit ALS - Lou Gehrig's Disease.


Lifestyle Editors/Calendar Editors

WAKEFIELD, Mass.--(BUSINESS WIRE)--July 18, 2003

The annual "Walk of Hope" for ALS ALS - Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
ALS - A Love Supreme (Sunderland AFC fanzine)
ALS - Accident Localization System
ALS - Accidental Limit States
ALS - Aceto Lactate Synthase
ALS - Achievement Levels Setting
ALS - Acquisition Logistics Support
ALS - Active Laser Seeker
ALS - Active Line State (Cisco)
ALS - Actual Loss Sustained
ALS - Ada Language System
ALS - Adaptive Learning System
ALS - Adjacent Link Station (IBM)
, a 3.5-mile walk around Lake Quannapowitt in Wakefield, Massachusetts, hosted by the Angel Fund and sponsored by the law firm of Nigro, Pettepit & Lucas of Wakefield, will be held on Saturday, September 6th. The event begins with registration on Wakefield Common at 9 a.m. followed by the walk at 11 a.m.

The Angel Fund is an independent, nonprofit organization dedicated to supporting Amyotrophic Lateral Sclerosis (ALS) investigation at Massachusetts General Hospital. Proceeds from the event will support research at the Cecil B. Day Neuromuscular neuromuscular /neu·ro·mus·cu·lar/ (-mus´ku-ler) pertaining to nerves and muscles, or to the relationship between them.

neu·ro·mus·cu·lar (nr
 Research Center run by Dr. Robert H. Brown, Jr.

ALS, more commonly known as Lou Gehrig's Disease, is a progressive, always fatal neuromuscular disease. ALS leads to muscle weakness and as it progresses, results in total paralysis and the inability to speak and swallow while the mind and senses remain intact.

Last year's Walk of Hope raised over $120,000 with over 600 walkers participating. In addition to the walk, the Angel Fund conducts other fund raising events throughout the year which, along with individual and corporate donations, have been beneficial in helping make significant strides in ALS research at Mass General.

Recent discoveries have improved understanding of the disease and have pointed to new concepts in ALS therapy. A gene defect causing one familial form of ALS was identified the mid-1990s that led to cell-based and animal models for ALS. As a result, researchers have been able to study the molecular biology of ALS and to test potential new treatments.

There are several levels of sponsorship for the "Walk of Hope" including raising money through pledges as a walker, becoming a sponsor or corporate sponsor, or making an individual donation as a general contributor, sustaining member or as a member of Ginny's Angel Society, in honor of ALS patient Ginny DelVecchio, the driving force behind The Angel Fund.

Corporate sponsorship includes three levels: $500 - Friends of the Angel Fund (company name displayed on posters at the event); $1,500 - Lake Sponsors (company name displayed at the event and the opportunity to display promotional materials), $2,500 Co-sponsor (will have the privilege of displaying their company banner, their company name on the printed poster and the event booklet, and the opportunity to display promotional material.)

Walkers can participate as individuals or as a team. The event will be held rain or shine and will include refreshments, entertainment, lunch, activities for kids, and prizes for the walkers who raise the most money. Each of the first 500 walkers to register will receive a t-shirt. REI has generously donated walk-related items to the walk.

To register as a walker, or to make a donation to the Angel Fund, please call Paul DelVecchio, Executive Director, at (781) 279-1422, or Lisa Courtenay, Fund Administrator at (781) 245-4545, or log-on to either the organization's website at www.theangelfund.org. Donations made payable to The Angel Fund can be sent to The Angel Fund, c/o Lisa Courtenay, 649 Main Street, Wakefield, MA 01880.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 18, 2003
Words:513
Previous Article:Fitch Upgrades 3 & Affirms 2 RMBS Classes From 1 RFMSI Securitization.
Next Article:Capital Growth Partners Acquires United Park City Mines Co.



Related Articles
BENEFIT FOR RETIRED CITY WORKER WITH ALS AN OVERWHELMING SUCCESS.(News)
5K RUN/WALK TO HELP LOCAL ALS PATIENT.(News)
5K RUN BENEFITS ALS SUFFERERS PARTICIPANTS NET $40,000 FOR TWO MEN.(News)
DRUG TEST RESULTS ON ALS PATIENTS DISAPPOINT AMGEN.(BUSINESS)(Statistical Data Included)
Are varsity athletes prone to ALS? (Neurology).(amyotrophic lateral sclerosis)(Brief Article)
EXONHIT INITIATES PHASE II CLINICAL TRIAL FOR EHT 0201.
Gulf War vets face elevated ALS risk.(Environment)
Lennard Katz, son of ALS victim, to head muscular dystrophy fight.(Transcripts)(Brief Article)
Proteins mark ALS.(Pathology)
TUNING THE NATION'S TV VIEWERS IN TO LOU GEHRIG'S DISEASE.(News)

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles